questionsmedicales.fr
Phénomènes psychologiques
Processus mentaux
Perception
Perception visuelle
Perception visuelle : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Perception visuelle : Questions médicales les plus fréquentes",
"headline": "Perception visuelle : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Perception visuelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-29",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Perception visuelle"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Perception",
"url": "https://questionsmedicales.fr/mesh/D010465",
"about": {
"@type": "MedicalCondition",
"name": "Perception",
"code": {
"@type": "MedicalCode",
"code": "D010465",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Clignement attentionnel",
"alternateName": "Attentional Blink",
"url": "https://questionsmedicales.fr/mesh/D054518",
"about": {
"@type": "MedicalCondition",
"name": "Clignement attentionnel",
"code": {
"@type": "MedicalCode",
"code": "D054518",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.145"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception des couleurs",
"alternateName": "Color Perception",
"url": "https://questionsmedicales.fr/mesh/D003118",
"about": {
"@type": "MedicalCondition",
"name": "Perception des couleurs",
"code": {
"@type": "MedicalCode",
"code": "D003118",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.217"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Perception du mouvement",
"alternateName": "Motion Perception",
"url": "https://questionsmedicales.fr/mesh/D009039",
"about": {
"@type": "MedicalCondition",
"name": "Perception du mouvement",
"code": {
"@type": "MedicalCode",
"code": "D009039",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.567"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Reconnaissance visuelle des formes",
"alternateName": "Pattern Recognition, Visual",
"url": "https://questionsmedicales.fr/mesh/D010364",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance visuelle des formes",
"code": {
"@type": "MedicalCode",
"code": "D010364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Reconnaissance faciale",
"alternateName": "Facial Recognition",
"url": "https://questionsmedicales.fr/mesh/D000066499",
"about": {
"@type": "MedicalCondition",
"name": "Reconnaissance faciale",
"code": {
"@type": "MedicalCode",
"code": "D000066499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.622.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Clôture perceptive",
"alternateName": "Perceptual Closure",
"url": "https://questionsmedicales.fr/mesh/D010466",
"about": {
"@type": "MedicalCondition",
"name": "Clôture perceptive",
"code": {
"@type": "MedicalCode",
"code": "D010466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.677"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision binoculaire",
"alternateName": "Vision, Binocular",
"url": "https://questionsmedicales.fr/mesh/D015348",
"about": {
"@type": "MedicalCondition",
"name": "Vision binoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015348",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.885"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vision monoculaire",
"alternateName": "Vision, Monocular",
"url": "https://questionsmedicales.fr/mesh/D015349",
"about": {
"@type": "MedicalCondition",
"name": "Vision monoculaire",
"code": {
"@type": "MedicalCode",
"code": "D015349",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F02.463.593.932.893"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Perception visuelle",
"alternateName": "Visual Perception",
"code": {
"@type": "MedicalCode",
"code": "D014796",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "J Farley Norman",
"url": "https://questionsmedicales.fr/author/J%20Farley%20Norman",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychological Sciences, Ogden College of Science and Engineering, Western Kentucky University, 1906 College Heights Blvd. #22030, Bowling Green, KY, 42101-2030, USA. farley.norman@wku.edu."
}
},
{
"@type": "Person",
"name": "Matan Mazor",
"url": "https://questionsmedicales.fr/author/Matan%20Mazor",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Rani Moran",
"url": "https://questionsmedicales.fr/author/Rani%20Moran",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK."
}
},
{
"@type": "Person",
"name": "Stephen M Fleming",
"url": "https://questionsmedicales.fr/author/Stephen%20M%20Fleming",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neurology, Wellcome Centre for Human Neuroimaging, University College London, London, UK."
}
},
{
"@type": "Person",
"name": "Johan Wagemans",
"url": "https://questionsmedicales.fr/author/Johan%20Wagemans",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Experimental Psychology, Department of Brain and Cognition, Faculty of Psychology and Educational Sciences, KU Leuven, Tiensestraat 102 - box 3711, 3000, Leuven, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Using the Correlation Intensity Index to Build a Model of Cardiotoxicity of Piperidine Derivatives.",
"datePublished": "2023-09-12",
"url": "https://questionsmedicales.fr/article/37764363",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules28186587"
}
},
{
"@type": "ScholarlyArticle",
"name": "MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin.",
"datePublished": "2022-12-14",
"url": "https://questionsmedicales.fr/article/36517751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s10020-022-00588-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Involvement of kallikrein-PAR2-proinflammatory pathway in severe trastuzumab-induced cardiotoxicity.",
"datePublished": "2022-08-19",
"url": "https://questionsmedicales.fr/article/35879248",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cas.15508"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α.",
"datePublished": "2022-07-23",
"url": "https://questionsmedicales.fr/article/35871160",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41419-022-05100-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cardiotoxicity model-based patient selection for Hodgkin lymphoma proton therapy.",
"datePublished": "2022-06-06",
"url": "https://questionsmedicales.fr/article/35668710",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/0284186X.2022.2084639"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes psychologiques",
"item": "https://questionsmedicales.fr/mesh/D011579"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus mentaux",
"item": "https://questionsmedicales.fr/mesh/D008606"
},
{
"@type": "ListItem",
"position": 4,
"name": "Perception",
"item": "https://questionsmedicales.fr/mesh/D010465"
},
{
"@type": "ListItem",
"position": 5,
"name": "Perception visuelle",
"item": "https://questionsmedicales.fr/mesh/D014796"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Perception visuelle - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Perception visuelle",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Perception visuelle",
"description": "Comment évaluer la perception visuelle ?\nQuels examens pour troubles de la perception ?\nQuels signes indiquent un problème visuel ?\nQuand consulter un spécialiste de la vue ?\nQuelles sont les causes de troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Cardiotoxicity&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Perception visuelle",
"description": "Quels symptômes de troubles de la perception ?\nComment reconnaître une illusion visuelle ?\nQu'est-ce que l'agnosie visuelle ?\nQuels signes d'une fatigue visuelle ?\nComment se manifeste la synesthésie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Cardiotoxicity&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Perception visuelle",
"description": "Comment prévenir les troubles de la perception ?\nQuel rôle joue l'alimentation sur la vision ?\nComment réduire la fatigue visuelle ?\nPourquoi éviter le tabac pour la vision ?\nL'exercice physique aide-t-il la vision ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Cardiotoxicity&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Perception visuelle",
"description": "Quels traitements pour troubles de la perception ?\nComment la thérapie visuelle aide-t-elle ?\nLes lunettes corrigent-elles la perception ?\nQuand envisager une chirurgie oculaire ?\nQuels médicaments pour troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Cardiotoxicity&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Perception visuelle",
"description": "Quelles complications des troubles visuels ?\nComment les troubles visuels affectent-ils la vie quotidienne ?\nQuels risques de dépression avec troubles visuels ?\nLes troubles de la perception peuvent-ils s'aggraver ?\nQuelles sont les conséquences d'une agnosie visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Cardiotoxicity&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Perception visuelle",
"description": "Quels facteurs de risque pour troubles visuels ?\nLe diabète augmente-t-il les risques visuels ?\nComment l'hypertension affecte-t-elle la vision ?\nLe stress influence-t-il la perception visuelle ?\nLes antécédents de traumatismes oculaires sont-ils un risque ?",
"url": "https://questionsmedicales.fr/mesh/D014796?mesh_terms=Cardiotoxicity&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la perception visuelle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de vision, comme l'optométrie, évaluent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quels examens pour troubles de la perception ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et l'électrorétinogramme aident à diagnostiquer les troubles de la perception."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un problème visuel ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des difficultés à voir, des illusions ou des distorsions visuelles peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste de la vue ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un ophtalmologiste si vous ressentez des changements soudains de vision."
}
},
{
"@type": "Question",
"name": "Quelles sont les causes de troubles visuels ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les causes incluent les maladies oculaires, les traumatismes et les troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes de troubles de la perception ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la vision floue, les halos, et les difficultés de profondeur."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une illusion visuelle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les illusions visuelles se manifestent par des perceptions erronées d'objets ou de couleurs."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'agnosie visuelle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle est l'incapacité de reconnaître des objets malgré une vision intacte."
}
},
{
"@type": "Question",
"name": "Quels signes d'une fatigue visuelle ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des maux de tête, des yeux secs et une vision floue après un usage prolongé."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la synesthésie visuelle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La synesthésie visuelle se manifeste par des associations involontaires entre couleurs et sons."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles de la perception ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Protégez vos yeux avec des lunettes de soleil et faites des examens réguliers."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation sur la vision ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en vitamines A, C et E peut aider à maintenir une bonne vision."
}
},
{
"@type": "Question",
"name": "Comment réduire la fatigue visuelle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Faites des pauses régulières lors de l'utilisation d'écrans pour réduire la fatigue visuelle."
}
},
{
"@type": "Question",
"name": "Pourquoi éviter le tabac pour la vision ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabac augmente le risque de maladies oculaires comme la dégénérescence maculaire."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il la vision ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine, bénéfique pour la santé oculaire."
}
},
{
"@type": "Question",
"name": "Quels traitements pour troubles de la perception ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie visuelle, les lunettes et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment la thérapie visuelle aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie visuelle améliore la coordination œil-main et la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les lunettes corrigent-elles la perception ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lunettes corrigent les erreurs de réfraction et améliorent la perception visuelle."
}
},
{
"@type": "Question",
"name": "Quand envisager une chirurgie oculaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée pour des problèmes structurels comme la cataracte ou le glaucome."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour troubles visuels ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent traiter des conditions comme le glaucome ou les infections oculaires."
}
},
{
"@type": "Question",
"name": "Quelles complications des troubles visuels ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, l'isolement social et des troubles émotionnels."
}
},
{
"@type": "Question",
"name": "Comment les troubles visuels affectent-ils la vie quotidienne ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent limiter les activités quotidiennes, affecter le travail et la mobilité."
}
},
{
"@type": "Question",
"name": "Quels risques de dépression avec troubles visuels ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles visuels augmentent le risque de dépression en raison de l'isolement social."
}
},
{
"@type": "Question",
"name": "Les troubles de la perception peuvent-ils s'aggraver ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, certains troubles de la perception peuvent s'aggraver avec le temps."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une agnosie visuelle ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle peut entraîner des difficultés dans la reconnaissance d'objets et des interactions sociales."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour troubles visuels ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et les maladies chroniques."
}
},
{
"@type": "Question",
"name": "Le diabète augmente-t-il les risques visuels ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut causer des complications oculaires comme la rétinopathie diabétique."
}
},
{
"@type": "Question",
"name": "Comment l'hypertension affecte-t-elle la vision ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension peut endommager les vaisseaux sanguins de l'œil, entraînant des troubles visuels."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la perception visuelle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la concentration et la clarté de la perception visuelle."
}
},
{
"@type": "Question",
"name": "Les antécédents de traumatismes oculaires sont-ils un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traumatismes oculaires augmentent le risque de troubles de la perception visuelle."
}
}
]
}
]
}
The assessment of cardiotoxicity is a persistent problem in medicinal chemistry. Quantitative structure-activity relationships (QSAR) are one possible way to build up models for cardiotoxicity. Here, ...
The use of doxorubicin is associated with an increased risk of acute and long-term cardiomyopathy. Despite the constantly growing number of cancer survivors, little is known about the transcriptional ...
We have sequenced miRNA from total plasma and extracellular vesicles (EVs) from 66 acute lymphoblastic leukemia (ALL) survivors and 61 healthy controls (254 samples in total). We then analyzed process...
We found that especially miRNAs contained within EVs may be informative in terms of cardiomyopathy development and may regulate pathways related to neurotrophin signaling, transforming growth factor b...
Our results show that transcriptomic changes resulting from doxorubicin induced myocardial injury are reflected in circulating miRNA levels and precede development of the late onset cardiomyopathy phe...
Trastuzumab-induced cardiotoxicity interferes with continued treatment in approximately 10% of patients with ErbB2-positive breast cancer, but its mechanism has not been fully elucidated. In this stud...
Doxorubicin (DOX)-based chemotherapy is widely used to treat malignant tumors; however, the cardiotoxicity induced by DOX restricts its clinical usage. A therapeutic dose of DOX can activate ubiquitin...
Hodgkin lymphoma (HL) is a highly curable hematological malignancy. Consolidation radiation therapy techniques have made significant progresses to improve organ-at-risk sparing in order to reduce late...
This retrospective dosimetric study included 30 mediastinal HL patients treated with VMAT. IMPT plans were generated on the initial simulation scans. Dose to the heart, to the left ventricle and to th...
Compared with VMAT, IMPT significantly reduced average mean doses to the heart (2.36 Gy vs 0.99 Gy,...
While a statistically significant clinical benefit is theoretically expected for ischemic heart disease, cardiac heart failure and valvular disease for mediastinal HL patients with IMPT, the overall c...
Doxorubicin is a valuable chemotherapeutic drug; however, it is associated with a high risk of cardiotoxicity. Several institutions and organizations have developed guidelines for risk factor assessme...
This review identified guidelines in literature from January 1960 to February 6, 2022, through a systematic search that included PubMed, EMBASE, MEDLINE, Cochrane Database and Google Scholar. The qual...
Eight guidelines met the inclusion criteria and 144 recommendations were extracted from these guidelines. The results from the AGREE II evaluation showed that the total assessment scores of guidelines...
All studied guidelines need modifications as per the AGREE II evaluating tool. Several shortcomings were identified, including a lack of evidence-based studies supporting the recommendations in the gu...
Doxorubicin (DOX) is an anthracycline antibiotic frequently used against a wide range of cancers, including breast cancer. Although the drug is effective as a treatment against cancer, many patients d...
Implementation of advanced echocardiographic techniques in cardio-oncology is a growing need as they are the cornerstone of early detection of cancer therapy-related cardiovascular toxicity (CTR-CVT)....
Three-dimensional echocardiography and myocardial deformation techniques have shown more accuracy and reproducibility than classic 2D measurements in detecting cardiovascular adverse effects in patien...
Doxorubicin (Dox) is a widely used anti-cancer drug that has a significant limitation, which is cardiotoxicity. Its cardiotoxic side effect is dose dependent and occurs through any age. Dox has been k...
This study was designed to examine the association between myocardial concentrations of the trace elements Cu, Fe, Mn, Mo, and Zn and the expression of mitochondrial unfolded protein response (UPRmt) ...